blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

Italy joins the Federated Register

Click here for more information on the Federated Register.

2025-06-12

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register User Manual
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP2434994

EP2434994 - RE-ESTABLISHMENT OF BLOOD FLOW IN BLOCKED HUMAN ARTERIES BY TRANSFERRING NANO-ENCAPSULATED DRUG THROUGH MEDICAL DEVICES, DESIGNED FOR THE SAME AND RELEASING THE NANO- ENCAPSULATED DRUG IN HUMAN ARTERY WITH BODY PH [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  17.05.2019
Database last updated on 18.03.2026
FormerThe patent has been granted
Status updated on  08.06.2018
FormerGrant of patent is intended
Status updated on  24.11.2017
FormerExamination is in progress
Status updated on  13.01.2017
Most recent event   Tooltip01.07.2022Lapse of the patent in a contracting state
New state(s): MK		published on 03.08.2022  [2022/31]
Applicant(s)For all designated states
Envision Scientific Private Limited
8 Narayan Darshan Apt. Opp. Rupam Cinema Salabatpura
Surat 395 002 Gujarat / IN
[2012/14]
Inventor(s)01 / DOSHI, Manish
703-704A Meghmalhar Apartment
Bhatar Char Rasta
Udhna Magdalla Road
Surat 395 017 Gujarat / IN
02 / SHERDIWALA, Divyesh
2/280 Moto Mohallo
Rustampura
Surat 395 017 Gujarat / IN
03 / SOJITRA, Prakash
92 Rajmandir Society
Near Yoggi Chowk
Puna-Simada Road
Surat 395 006 Gujarat / IN
04 / VYAS, Ashwin
B-7 Sai Nagar
Maninagar
Amreli 395 601 Gujarat / IN
05 / GANDHI, Pankai
3/2444-B Tadwali Street
Nr.Police Station
Salabatpura
Surat Gujarat / IN
06 / MURTHY, Zagabathuni, Venkata, Panchakshari
C-406 Pragati Nagar
Piplod
Surat Gujarat / IN
 [2012/14]
Representative(s)Viering, Jentschura & Partner mbB Patent- und Rechtsanwälte
Hamborner Straße 53
40472 Düsseldorf / DE
[N/P]
Former [2018/28]Viering, Jentschura & Partner mbB Patent- und Rechtsanwälte
Kennedydamm 55 / Roßstrasse
40476 Düsseldorf / DE
Former [2014/13]Viering, Jentschura & Partner Patent- und Rechtsanwälte
Kennedydamm 55 / Roßstrasse
40476 Düsseldorf / DE
Former [2012/14]Viering, Jentschura & Partner
Grillparzerstrasse 14
81675 München / DE
Application number, filing date10780159.921.05.2010
[2018/28]
WO2010IN00347
Priority number, dateIN2009MUM132429.05.2009         Original published format: IN 1324MU2009
[2017/16]
Former [2012/14]IN2009MUM132429.05.2009
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report
No.:WO2010137037
Date:02.12.2010
Language:EN
[2010/48]
Type: A2 Application without search report 
No.:EP2434994
Date:04.04.2012
Language:EN
The application published by WIPO in one of the EPO official languages on 02.12.2010 takes the place of the publication of the European patent application.
[2012/14]
Type: B1 Patent specification 
No.:EP2434994
Date:11.07.2018
Language:EN
[2018/28]
Search report(s)International search report - published on:CN27.01.2011
(Supplementary) European search report - dispatched on:EP20.12.2013
ClassificationIPC:A61F2/82, A61M29/00, A61M31/00, A61L31/16
[2012/14]
CPC:
A61L31/16 (EP,RU,US); A61F2/82 (RU,US); A61F2/958 (US);
A61L29/08 (US); A61L29/16 (EP,US); A61L31/08 (US);
A61M25/0043 (EP,US); A61P9/00 (EP); A61P9/10 (EP);
A61F2250/0067 (EP,US); A61L2300/416 (US); A61L2300/606 (US);
A61L2300/608 (EP,US); A61L2300/624 (EP,US); A61L2400/12 (EP,US);
A61L2420/06 (US); A61M2025/0057 (EP,US); A61M2025/105 (EP,US);
A61M29/00 (RU); A61M31/00 (RU); B32B9/04 (RU);
B82B1/00 (RU) (-)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   SE,   SI,   SK,   SM,   TR [2012/14]
Extension statesBANot yet paid
MENot yet paid
RSNot yet paid
TitleGerman:WIEDERHERSTELLUNG DES BLUTFLUSSES IN VERSTOPFTEN MENSCHLICHEN ARTERIEN DURCH EINFÜHREN EINES NANOGEKAPSELTEN WIRKSTOFFS DURCH EINE MEDIZINISCHE VORRICHTUNG, DIE DAFÜR AUSGELEGT IST UND FREISETZEN DES NANOVERKAPSELTEN WIRKSTOFFS IN DIE MENSCHLICHE ARTERIE MIT KÖRPER-PH-WERT[2018/23]
English:RE-ESTABLISHMENT OF BLOOD FLOW IN BLOCKED HUMAN ARTERIES BY TRANSFERRING NANO-ENCAPSULATED DRUG THROUGH MEDICAL DEVICES, DESIGNED FOR THE SAME AND RELEASING THE NANO- ENCAPSULATED DRUG IN HUMAN ARTERY WITH BODY PH[2012/14]
French:RÉTABLISSEMENT DE LA CIRCULATION SANGUINE DANS DES ARTÈRES HUMAINES BLOQUÉES PAR TRANSFERT DE MÉDICAMENT NANO-ENCAPSULÉ PAR DES DISPOSITIFS MÉDICAUX, CONÇUS À CET EFFET ET LIBÉRATION DE MÉDICAMENT NANOENCAPSULÉ AYANT LE PH DU CORPS DANS DES ARTÈRES HUMAINES[2012/14]
Former [2012/14]WIEDERHERSTELLUNG DES BLUTFLUSSES IN VERSTOPFTEN MENSCHLICHEN ARTERIEN DURCH EINFÜHRUNG EINES NANOGEKAPSELTEN ARZNEIMITTELS MITTELS MEDIZINISCHER GERÄTE SOWIE DAFÜR UND FÜR DIE FREIGABE DES NANOGEKAPSELTEN ARZNEIMITTELS IN EINE MENSCHLICHE ARTERIE ENTWICKELTE GERÄTE MIT KÖRPER-PH-WERT
Entry into regional phase24.10.2011National basic fee paid 
24.10.2011Search fee paid 
24.10.2011Designation fee(s) paid 
24.10.2011Examination fee paid 
Examination procedure24.10.2011Examination requested  [2012/14]
07.07.2014Amendment by applicant (claims and/or description)
29.08.2016Despatch of a communication from the examining division (Time limit: M04)
05.01.2017Reply to a communication from the examining division
07.11.2017Cancellation of oral proceeding that was planned for 09.11.2017
09.11.2017Date of oral proceedings (cancelled)
22.11.2017Communication of intention to grant the patent
16.03.2018Fee for grant paid
16.03.2018Fee for publishing/printing paid
16.03.2018Receipt of the translation of the claim(s)
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  29.08.2016
Opposition(s)12.04.2019No opposition filed within time limit [2019/25]
Fees paidRenewal fee
31.05.2012Renewal fee patent year 03
29.11.2013Renewal fee patent year 04
28.05.2014Renewal fee patent year 05
28.05.2015Renewal fee patent year 06
30.05.2016Renewal fee patent year 07
30.05.2017Renewal fee patent year 08
30.05.2018Renewal fee patent year 09
Penalty fee
Additional fee for renewal fee
31.05.201304   M06   Fee paid on   29.11.2013
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU21.05.2010
AL11.07.2018
CY11.07.2018
EE11.07.2018
HR11.07.2018
LT11.07.2018
LV11.07.2018
MC11.07.2018
MK11.07.2018
MT11.07.2018
RO11.07.2018
SI11.07.2018
SK11.07.2018
SM11.07.2018
BG11.10.2018
IS11.11.2018
PT11.11.2018
[2022/31]
Former [2021/34]HU21.05.2010
AL11.07.2018
CY11.07.2018
EE11.07.2018
HR11.07.2018
LT11.07.2018
LV11.07.2018
MC11.07.2018
MT11.07.2018
RO11.07.2018
SI11.07.2018
SK11.07.2018
SM11.07.2018
BG11.10.2018
IS11.11.2018
PT11.11.2018
Former [2021/32]HU21.05.2010
AL11.07.2018
CY11.07.2018
EE11.07.2018
HR11.07.2018
LT11.07.2018
LV11.07.2018
MC11.07.2018
RO11.07.2018
SI11.07.2018
SK11.07.2018
SM11.07.2018
BG11.10.2018
IS11.11.2018
PT11.11.2018
Former [2021/26]AL11.07.2018
CY11.07.2018
EE11.07.2018
HR11.07.2018
LT11.07.2018
LV11.07.2018
MC11.07.2018
RO11.07.2018
SI11.07.2018
SK11.07.2018
SM11.07.2018
BG11.10.2018
IS11.11.2018
PT11.11.2018
Former [2020/29]AL11.07.2018
EE11.07.2018
HR11.07.2018
LT11.07.2018
LV11.07.2018
MC11.07.2018
RO11.07.2018
SI11.07.2018
SK11.07.2018
SM11.07.2018
BG11.10.2018
IS11.11.2018
PT11.11.2018
Former [2020/07]AL11.07.2018
EE11.07.2018
HR11.07.2018
LT11.07.2018
LV11.07.2018
MC11.07.2018
RO11.07.2018
SI11.07.2018
SK11.07.2018
SM11.07.2018
BG11.10.2018
IS11.11.2018
Former [2019/37]AL11.07.2018
EE11.07.2018
HR11.07.2018
LT11.07.2018
LV11.07.2018
RO11.07.2018
SI11.07.2018
SK11.07.2018
SM11.07.2018
BG11.10.2018
IS11.11.2018
Former [2019/26]AL11.07.2018
EE11.07.2018
HR11.07.2018
LT11.07.2018
LV11.07.2018
RO11.07.2018
SK11.07.2018
SM11.07.2018
BG11.10.2018
IS11.11.2018
Former [2019/24]AL11.07.2018
EE11.07.2018
HR11.07.2018
LT11.07.2018
LV11.07.2018
RO11.07.2018
SK11.07.2018
BG11.10.2018
IS11.11.2018
Former [2019/22]AL11.07.2018
HR11.07.2018
LT11.07.2018
LV11.07.2018
RO11.07.2018
BG11.10.2018
IS11.11.2018
Former [2019/12]AL11.07.2018
HR11.07.2018
LT11.07.2018
LV11.07.2018
BG11.10.2018
IS11.11.2018
Former [2019/08]LT11.07.2018
IS11.11.2018
Former [2019/07]LT11.07.2018
Documents cited:Search[XI] US2006204738  (DUBROW ROBERT S et al.) [X] 1-5,8,16-23 * paragraph [0009] - paragraph [0012]; claim - *[I] 6,7,9-15
 [XI] US2009099651  (HAKIMI-MEHR DORNA et al.) [X] 1-5,8,16-23 * paragraphs [0059] , [0 66] , [0 81] , [ 111]; claim - *[I] 6,7,9-15
 [I] US2005095267  (CAMPBELL TODD et al.) [I] 6,7,9-15 * paragraphs [0005] , [0 29] , [0 42] , [0 43]; claim - *
 [E] WO2010140163  (CONCEPT MEDICAL INC et al.) [E] 1-23 * the whole document *
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.